T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Enliven Therapeutics
ELVN
$4.25B
| $262K | ﹤0.01% |
+11,207
| New | +$236K |
|
2477
MiMedx Group
MDXG
$624M
| $262K | ﹤0.01% |
37,747
+4,769
| +14% | +$33.5K |
|
2478
Digital Turbine
APPS
$1.53B
| $261K | ﹤0.01% |
156,897
+44,100
| +39% | +$85.5K |
|
2479
Aurinia Pharmaceuticals
AUPH
$2.02B
| $261K | ﹤0.01% |
45,707
+6,755
| +17% | +$35.6K |
|
2480
Cardlytics
CDLX
$25.1M
| $260K | ﹤0.01% |
3,157
+180
| +6% | +$19.5K |
|
|
DESP
2481
DELISTED
Despegar.com
DESP
| $259K | ﹤0.01% |
+19,575
| New | +$258K |
|
2482
Bank First Corp
BFC
$1.74B
| $258K | ﹤0.01% |
3,121
+445
| +17% | +$35.9K |
|
2483
Nordic American Tanker
NAT
$1.4B
| $257K | ﹤0.01% |
64,347
+5,556
| +9% | +$22.3K |
|
2484
Blink Charging
BLNK
$87.1M
| $256K | ﹤0.01% |
93,322
+15,151
| +19% | +$43.3K |
|
2485
Montauk Renewables
MNTK
$265M
| $256K | ﹤0.01% |
44,905
+1,576
| +4% | +$7.29K |
|
|
DCH
2486
Dauch Corp
DCH
$1.61B
| $253K | ﹤0.01% |
36,183
+3,458
| +11% | +$25.5K |
|
|
SPWR
2487
DELISTED
SunPower Corporation Common Stock
SPWR
| $252K | ﹤0.01% |
84,936
+2,353
| +3% | +$6.42K |
|
|
AMK
2488
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $251K | ﹤0.01% |
7,261
+983
| +16% | +$33.9K |
|
|
PLGO
2489
Pelagos Insurance Capital
PLGO
$2.08B
| $250K | ﹤0.01% |
15,296
-1,960
| -11% | -$34.7K |
|
2490
GoPro
GPRO
$117M
| $250K | ﹤0.01% |
175,826
+42,300
| +32% | +$70.6K |
|
2491
Innodata
INOD
$2.03B
| $250K | ﹤0.01% |
16,844
+1,496
| +10% | +$15.5K |
|
2492
Canterbury Park Holding Corp
CPHC
$80.8M
| $249K | ﹤0.01% |
11,379
| – | – |
|
2493
Ducommun
DCO
$3.04B
| $249K | ﹤0.01% |
+4,283
| New | +$239K |
|
|
FIRY
2494
Firy Inc
FIRY
$158M
| $249K | ﹤0.01% |
34,592
| – | – |
|
2495
The Joint Corp
JYNT
$119M
| $248K | ﹤0.01% |
17,586
+122
| +0.7% | +$1.74K |
|
2496
Mastech Digital
MHH
$95.3M
| $247K | ﹤0.01% |
32,884
| – | – |
|
2497
Regenxbio
RGNX
$704M
| $247K | ﹤0.01% |
21,100
+2,923
| +16% | +$45.5K |
|
2498
Editas Medicine
EDIT
$432M
| $245K | ﹤0.01% |
52,455
+2,751
| +6% | +$15.5K |
|
2499
Lifestance Health
LFST
$4.67B
| $245K | ﹤0.01% |
49,831
+7,465
| +18% | +$45K |
|
2500
ProPetro Holding
PUMP
$1.42B
| $244K | ﹤0.01% |
28,128
+510
| +2% | +$4.55K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.